ALLIQUA BIOMEDICAL INC's ticker is ALQA and the CUSIP is 019621200. A total of 31 filers reported holding ALLIQUA BIOMEDICAL INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $30,916,000 | +1874.2% | 8,467,902 | +100.0% | 0.59% | +646.8% |
Q2 2017 | $1,566,000 | -26.7% | 4,233,951 | 0.0% | 0.08% | -35.2% |
Q1 2017 | $2,136,000 | +88.5% | 4,233,951 | +120.3% | 0.12% | +50.6% |
Q4 2016 | $1,133,000 | -26.3% | 1,921,951 | 0.0% | 0.08% | -18.2% |
Q3 2016 | $1,537,000 | -76.3% | 1,921,951 | +145.0% | 0.10% | -85.4% |
Q1 2014 | $6,472,000 | +60.2% | 784,594 | +40.7% | 0.68% | +40.2% |
Q4 2013 | $4,041,000 | – | 557,491 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 839,100 | $1,796,000 | 0.62% |
PURA VIDA INVESTMENTS, LLC | 523,000 | $1,119,000 | 0.47% |
SENZAR ASSET MANAGEMENT, LLC | 1,014,103 | $2,170,180,000 | 0.24% |
SUFFOLK CAPITAL MANAGEMENT LLC | 870,996 | $1,864,000 | 0.24% |
J. Goldman & Co LP | 822,549 | $1,760,000 | 0.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,880,134 | $4,023,000 | 0.16% |
Tekla Capital Management LLC | 1,650,000 | $3,531,000 | 0.13% |
Anson Funds Management LP | 160,925 | $344,000 | 0.11% |
SABBY MANAGEMENT, LLC | 664,791 | $1,423,000 | 0.08% |
Chicago Partners Investment Group LLC | 12,906 | $28,000 | 0.01% |